Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

Subjects:

Baseline descriptive characteristics of trial participants with dizziness, by treatment group. by Anneli Peolsson (7867601)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects:

The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

Subjects:

Table 1_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx by Stefanie Wagner (743707)

“…These results were not detectable by standard 16S analysis based on relative abundances. Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Table 3_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx by Stefanie Wagner (743707)

“…These results were not detectable by standard 16S analysis based on relative abundances. Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Table 4_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx by Stefanie Wagner (743707)

“…These results were not detectable by standard 16S analysis based on relative abundances. Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Table 8_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx by Stefanie Wagner (743707)

“…These results were not detectable by standard 16S analysis based on relative abundances. Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Table 2_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx by Stefanie Wagner (743707)

“…These results were not detectable by standard 16S analysis based on relative abundances. Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Table 6_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx by Stefanie Wagner (743707)

“…These results were not detectable by standard 16S analysis based on relative abundances. Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”